Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Kunming Pharmaceutical Corp obtains GMP permit


Monday, 6 Jan 2014 07:00pm EST 

Kunming Pharmaceutical Corp:Says obtained a goods manufacturing practice (GMP) permit from Food and Drug Administration, for its small volume injections, with a valid period until Dec. 22, 2018.